In 2014, two independent groups found lenalidomide-dependent CRL4CRBN substrates, Ikaros (IKZF1) and Aiolos (IKZF3), in multiple myeloma cell lines [57,58]. Here, IKZF1 is linked to plasma cell myeloma.